Clovis Oncology Inc. Stock
Your prediction
Clovis Oncology Inc. Stock
Our community identified positive and negative aspects for Clovis Oncology Inc. stock for the coming years. 2 users see the criterium "Shareholder structure" as a plus for the Clovis Oncology Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Clovis Oncology Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clovis Oncology Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Clovis Oncology Inc. | - | - | - | - | - | - | - |
Ardelyx Inc. | -3.830% | 31.475% | 16.607% | 106.772% | 36.298% | 41.946% | - |
Evolus Inc | 0.830% | 12.150% | -0.826% | 52.866% | 32.597% | 63.265% | - |
Salarius Pharmaceuticals Inc. | -0.980% | -0.971% | -0.971% | -77.826% | -26.486% | -98.326% | -99.993% |